July 2026 in “Journal of the American Academy of Dermatology” Finasteride may lower depression risk in younger men with hair loss but increase it in older men with prostate issues.
December 2025 in “Cureus” In this retrospective cohort study, researchers found that patients with androgenetic alopecia using 5α-reductase inhibitors had a significantly higher risk of developing dry eye disease compared to those not using these medications.
August 2025 in “Journal of the American Academy of Dermatology” 
September 2024 in “Journal of the American Academy of Dermatology” This study observed that among patients starting Semaglutide therapy at 0.25-2mg weekly, approximately 0.80-0.83% reported non-scarring hair loss within six months, suggesting the drug does not significantly increase hair loss risk.
July 2026 in “Journal of the European Academy of Dermatology and Venereology” JAK inhibitors may reduce depression risk in alopecia areata patients.